In addition to NGR peptides, CD13 is targeted by a variety of different compounds [43] and bestatin has been reported to increase the overall survival of patients with early-stage squamous cell lung cancer when given after surgery in a randomized trial [44]. The gene discussed is RTN4R; the disease is squamous cell lung carcinoma.